He Y - Search Results

1

Clinical Outcomes and Prognostic Analysis of 101 Patients of Central Neurocytoma: A 10-Year Treatment Experience at a Single Institution.

Xie Q, Xie B, Ou L, Wang M, Tang Z, He Y, Yang X, Hong J, Lyu Z, Wei R. Xie Q, et al. Among authors: he y. Front Oncol. 2022 May 27;12:881460. doi: 10.3389/fonc.2022.881460. eCollection 2022. Front Oncol. 2022. PMID: 35692765 Free PMC article.

2

Role of enhanced radiosensitivity and the tumor-specific suicide gene vector in gene therapy of nasopharyngeal carcinoma.

Jiang W, Liao Y, Zhao S, Wu B, Zhou R, Wei R, Zhang J, He Y, Wu H. Jiang W, et al. Among authors: he y. J Radiat Res. 2007 May;48(3):211-8. doi: 10.1269/jrr.06056. Epub 2007 Apr 27. J Radiat Res. 2007. PMID: 17464096 Free article.

3

A retrospective study of the prognostic value of MRI-derived residual tumors at the end of intensity-modulated radiotherapy in 358 patients with locally-advanced nasopharyngeal carcinoma.

He Y, Zhou Q, Shen L, Zhao Y, Lei M, Wei R, Shen L, Cao S. He Y, et al. Radiat Oncol. 2015 Apr 15;10:89. doi: 10.1186/s13014-015-0401-0. Radiat Oncol. 2015. PMID: 25881159 Free PMC article.

4

Prognostic analysis of patients with locally advanced nasopharyngeal carcinoma following intensity modulated radiation therapy.

Zhao Y, Shen L, Huang X, He Y, Fu J, Qian Y, Li S, Zhao N, Shen L. Zhao Y, et al. Among authors: he y. Oncol Lett. 2018 Apr;15(4):4445-4450. doi: 10.3892/ol.2018.7850. Epub 2018 Jan 24. Oncol Lett. 2018. PMID: 29552107 Free PMC article.

5

Impact of paranasal sinus invasion on advanced nasopharyngeal carcinoma treated with intensity-modulated radiation therapy: the validity of advanced T stage of AJCC/UICC eighth edition staging system.

Wang Y, Zhao J, Zhao Y, Yang Z, Lei M, Li Z, Wei R, Chen D, He Y, Shen L. Wang Y, et al. Among authors: he y. Cancer Med. 2018 Jul;7(7):2826-2836. doi: 10.1002/cam4.1506. Epub 2018 May 1. Cancer Med. 2018. PMID: 29717544 Free PMC article.

6

Prognostic value and predictive threshold of tumor volume for patients with locally advanced nasopharyngeal carcinoma receiving intensity-modulated radiotherapy.

He YX, Wang Y, Cao PF, Shen L, Zhao YJ, Zhang ZJ, Chen DM, Yang TB, Huang XQ, Qin Z, Dai YY, Shen LF. He YX, et al. Chin J Cancer. 2016 Nov 16;35(1):96. doi: 10.1186/s40880-016-0159-2. Chin J Cancer. 2016. PMID: 27852284 Free PMC article.

7

Efficacy and Safety of Locoregional Radiotherapy With Chemotherapy vs Chemotherapy Alone in De Novo Metastatic Nasopharyngeal Carcinoma: A Multicenter Phase 3 Randomized Clinical Trial.

You R, Liu YP, Huang PY, Zou X, Sun R, He YX, Wu YS, Shen GP, Zhang HD, Duan CY, Tan SH, Cao JY, Li JB, Xie YL, Zhang YN, Wang ZQ, Yang Q, Lin M, Jiang R, Zhang MX, Hua YJ, Tang LQ, Zhuang AH, Chen QY, Guo L, Mo HY, Chen Y, Mai HQ, Ling L, Liu Q, Chua MLK, Chen MY. You R, et al. Among authors: he yx. JAMA Oncol. 2020 Sep 1;6(9):1345-1352. doi: 10.1001/jamaoncol.2020.1808. JAMA Oncol. 2020. PMID: 32701129 Free PMC article. Clinical Trial.

8

Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trial.

Lv X, Cao X, Xia WX, Liu KY, Qiang MY, Guo L, Qian CN, Cao KJ, Mo HY, Li XM, Li ZH, Han F, He YX, Liu YM, Wu SX, Bai YR, Ke LR, Qiu WZ, Liang H, Liu GY, Miao JJ, Li WZ, Lv SH, Chen X, Zhao C, Xiang YQ, Guo X. Lv X, et al. Lancet Oncol. 2021 May;22(5):716-726. doi: 10.1016/S1470-2045(21)00075-9. Epub 2021 Apr 12. Lancet Oncol. 2021. PMID: 33857411 Clinical Trial.

9

Exosomal circRNAs: Emerging Players in Tumor Metastasis.

Zhou H, He X, He Y, Ou C, Cao P. Zhou H, et al. Among authors: he x, he y. Front Cell Dev Biol. 2021 Dec 8;9:786224. doi: 10.3389/fcell.2021.786224. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34957113 Free PMC article. Review.

10

Advances of DNA Damage Repair-Related Drugs and Combination With Immunotherapy in Tumor Treatment.

Wang Y, Duan M, Peng Z, Fan R, He Y, Zhang H, Xiong W, Jiang W. Wang Y, et al. Among authors: he y. Front Immunol. 2022 Feb 23;13:854730. doi: 10.3389/fimmu.2022.854730. eCollection 2022. Front Immunol. 2022. PMID: 35281059 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40,004 results

Search Page

Filters